Lectil (Betahistine Dihydrochloride)

Betahistine Dihydrochloride acts as a partial agonist at histamine H1 receptors and an antagonist at H3 receptors. This dual mechanism increases histamine release, leading to vasodilation of the inner‑ear microvasculature and enhanced endolymphatic fluid turnover, which together alleviate vestibular symptoms.

The specific dosage of Lectil is determined by the prescribing healthcare professional based on the individual’s clinical condition, age, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose without medical advice.

Safety data for Betahistine Dihydrochloride in pregnancy and lactation are limited. It should only be used if the potential therapeutic benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To request Lectil, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with other anti‑vertigo agents such as diuretics or vestibular suppressants, Lectil’s histamine‑modulating action specifically targets inner‑ear microcirculation. This mechanism can provide symptom relief without the sedative effects commonly associated with antihistamines or benzodiazepines.

Lectil should be stored at ambient temperature below 25 °C. Keep the product in its original packaging, protect it from moisture, and avoid exposure to direct sunlight to maintain stability and potency.

Lectil is taken orally, usually with or without food, as directed by the prescribing clinician. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

Serious adverse reactions, although rare, include severe allergic responses such as anaphylaxis, marked hypotension, cardiac arrhythmias, and significant hepatic or hematologic abnormalities. Patients should seek immediate medical attention if they experience any of these symptoms.

Lectil is contraindicated in individuals with known hypersensitivity to betahistine or any of its excipients. Caution is also advised for patients with uncontrolled hypertension, severe cardiac disease, or those taking strong antihistamines that may negate its therapeutic effect.